In this article, we will look at 11 Newly-Listed NASDAQ Stocks to Buy Now.

IPO activity is starting to recover after a quiet stretch. In its Market Outlook 2026 entitled “Forging Ahead”, HarbourVest Partners noted that “IPO activity has accelerated,” adding that “strong aftermarket performance suggests the window will remain open into 2026.” That second point carries weight. A spike in new listings can fade quickly, but strong trading performance after companies go public usually signals that investors are not just chasing allocations on day one; they remain committed after the stocks begin to trade.

HarbourVest also described the broader backdrop as “cautiously optimistic,” wahile acknowledging that risks remain. A supportive but selective environment tends to reward companies that can execute rather than simply tell a compelling story. When fresh listings hold their ground after debuting, it reduces the perceived penalty for coming public and encourages more issuers to test the market. It also gives investors a wider opportunity set beyond the established large-cap names that have dominated indices.

A functioning IPO window is not just about volume. It reflects improving confidence, capital availability, and appetite for equity risk. With issuance picking up and aftermarket resilience holding, newly listed names are back in focus. Against that backdrop, we take a closer look at 11 Newly-Listed NASDAQ Stocks to Buy Now.

Our Methodology

To identify the 11 Newly-Listed NASDAQ Stocks to Buy Now, we used the Finviz screener to generate a list of stocks that have listed on NASDAQ within the past 12 months. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

11. EquipmentShare.com Inc. (NASDAQ:EQPT)

On February 17, 2026, UBS initiated coverage of EquipmentShare.com Inc. (NASDAQ:EQPT) with a Neutral rating and a $36 price target. UBS said EquipmentShare is positioned to outgrow the equipment rental market as it plans to double branch locations over five years, which could justify a premium multiple versus peers. However, UBS added that current valuations appear to fairly balance the company’s growth prospects with business complexities.

Also on February 17, 2026, Oppenheimer initiated coverage with an Outperform rating and a $39 price target. Oppenheimer noted EquipmentShare has grown organically over the past decade to become the fourth-largest competitor in the $84B U.S. equipment rental industry, highlighting its T3 telematics platform as a key differentiator that provides real-time asset data and has helped win a high percentage of mega project bids. Truist began coverage the same day with a Buy rating and a $43 price target, citing $4.4B in trailing twelve-month sales, an $8.8B fleet, a diversified customer base, and above-average organic growth. Truist said the company’s expansion strategy and proprietary T3 platform position it to benefit from mega project spending and a potential recovery in North American construction. Baird also initiated coverage with an Outperform rating and a $63 price target, pointing to the company’s “differentiated capital-lite growth model” and plans to add 70-80 branch locations annually through 2030, indicating potential for mid-20% annual sales growth.

EquipmentShare.com Inc. (NASDAQ:EQPT) provides integrated construction solutions across equipment rental, sales, and technology through its digitally native equipment rental platform servicing jobsites nationwide.

10. Gemini Space Station, Inc. (NASDAQ:GEMI)

On February 20, 2026, Rosenblatt analyst Chris Brendler lowered the price target on Gemini Space Station, Inc. (NASDAQ:GEMI) to $11.50 from $26 and maintained a Buy rating. Chris Brendler said Gemini is “now in full restructuring mode” just five months after what had appeared to be a successful IPO. Chris Brendler reduced revenue and adjusted EBITDA estimates due to tougher market conditions, but noted the stock has fallen nearly 80% from its IPO price and remains highly levered to a potential crypto rebound.

On February 18, 2026, Needham lowered its price target on Gemini to $10 from $23 and kept a Buy rating, citing a “major leadership restructuring” tied to the company’s Q4 pre-announcement, along with worsening expense and crypto volume outlooks.

On February 17, 2026, Gemini disclosed that as of December 31, 2025, it served approximately 600,000 Monthly Transacting Users, up 17% year over year. Net revenue for 2025 is expectedto be between $165 million and $175 million compared to $141 million in 2024, driven primarily by higher services revenue and credit card growth. Transaction revenue is projected at $93M-$99M and services revenue at $72M-$76M. Total operating expenses are expected to be between $520M-$530M versus $308M in 2024, largely due to personnel-related costs, technology investments, general and administrative expenses, and marketing. Adjusted EBITDA is expected between ($267M)-($257M), including net realized and unrealized losses of $30M-$35M. The regulatory filing confirmed the company will be “parting ways” with Chief Operating Officer Marshall Beard, Chief Financial Officer Dan Chen, and Chief Legal Officer Tyler Meade, effective February 17. Gemini said Beard’s resignation was “not the result of any disagreement,” and noted that Cameron Winklevoss will assume certain responsibilities. Danijela Stojanovic was appointed Interim CFO, and Kate Freedman was appointed Interim General Counsel.

Gemini Space Station, Inc. (NASDAQ:GEMI) operates a crypto platform offering trading, custody, derivatives, staking, stablecoin services, a U.S. credit card, and Web3-related services for digital assets, including bitcoin and ether.

9. Heartflow, Inc. (NASDAQ:HTFL)

On February 12, 2026, Heartflow, Inc. (NASDAQ:HTFL) announced an expansion of its GAMEFILM Registry. Initially focused on retired National Football League athletes, the study will now include former players from the National Basketball Association and the National Hockey League, broadening the initiative to additional professional sports. Chief Executive Officer John Farquhar said, “Expanding our GAMEFILM Registry to include NBA and NHL athletes marks a pivotal moment for Heartflow,” adding that the company’s diagnostic capabilities are intended to support athlete health and generate insights for cardiovascular care.

In late January 2026, Wells Fargo initiated coverage of Heartflow, Inc. (NASDAQ:HTFL) with an Overweight rating and a $38 price target. Wells Fargo cited upside to Street estimates driven by the company’s fractional flow reserve-computed tomography and plaque volume analyses. Wells Fargo described Heartflow, Inc. (NASDAQ:HTFL) as having a “strong first mover advantage” in software and AI-based diagnosis and management of coronary artery disease and expects approximately 20% growth over the next three years, supported by its FFRCT and plaque offerings.

Heartflow, Inc. (NASDAQ:HTFL) is a medical technology company that provides non-invasive solutions for diagnosing and managing coronary artery disease using AI and computational fluid dynamics to create personalized 3D heart models from coronary CT scans.

8. Chagee Holdings Limited (NASDAQ:CHA)

On February 13, 2026, JPMorgan analyst Jessie Xu upgraded Chagee Holdings Limited (NASDAQ:CHA) to Neutral from Underweight and lowered the price target to $11.50 from $12.40 previously. Jessie Xu said the company is “approaching a pivot point” in 2026 following five consecutive quarters of same-store-sales declines. JPMorgan’s Jessie Xu also noted that the share price of Chagee Holdings Limited (NASDAQ:CHA) has fallen more than 60% from the IPO price of $28 and sees improved risk/reward at current levels, citing the new initiatives that could support a turnaround in 2026.

Earlier in the year, in January 2026, Jefferies initiated their coverage of Chagee Holdings Limited (NASDAQ:CHA) with a Hold rating and a $14 price target as part of their broader coverage of leading China freshly-made drink brands. Jefferies said that it still prefers Guming and Mixue (MXUGF) over Chagee Holdings Limited (NASDAQ:CHA) based on growth visibility within the group.

Chagee Holdings Limited (NASDAQ:CHA) owns, operates, and franchises teahouses under the CHAGEE brand in China and internationally, and sells tea drinks, raw materials, packaging, equipment, and related supplies.

7. Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)

On February 9, 2026, Raymond James upgraded Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) to Strong Buy from Outperform with an unchanged $23 price target. Raymond James cited valuation following the recent selloff, noting that Lumexa trades at a six-times EBITDA discount to RadNet (RDNT). Raymond James believes some discount is warranted but sees “several factors that should help narrow the gap over time,” including what it described as a “superior and more well-defined” external growth strategy, stronger local market fundamentals, and a growing joint venture mix.

In January 2026, multiple firms initiated coverage. Barclays began coverage on Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) with an Overweight rating and a $23 price target, highlighting strong local market positions and accelerating new center openings, as well as rising demand for diagnostic imaging tied to chronic disease trends and a shift toward lower-cost care sites. Deutsche Bank initiated Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) with a Buy rating and a $22 price target, describing Lumexa as the second-largest independent diagnostic testing facility operator in the U.S. and pointing to share gains versus hospital outpatient facilities and an expanding advanced imaging mix. Wells Fargo also initiated Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) with an Overweight rating and a $22 price target, calling the company’s growth “attractive” within an end market benefiting from lower service costs and improved patient experience.

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) operates outpatient diagnostic imaging centers in the United States, offering MRI, CT, PET, X-ray, ultrasound, and mammography services.

6. Black Rock Coffee Bar, Inc. (NASDAQ:BRCB)

On February 13, 2026, Black Rock Coffee Bar, Inc. (NASDAQ:BRCB) announced that it is expanding into Austin with the opening of its first location along the Riverside corridor within city limits. Chief Executive Officer Mark Davis said, “The opening of the new Riverside location is a huge moment for us as a brand,” noting that the site brings the company closer to downtown and makes it more accessible for city residents as it continues growing in the Austin area.

On January 21, 2026, Raymond James analyst Brian Vaccaro lowered the price target on Black Rock Coffee Bar, Inc. (NASDAQ:BRCB) to $26 from $28 previously and maintained an Outperform rating. Brian Vaccaro said restaurant stocks have outperformed year to date amid a January comp rebound and short covering, even as fourth-quarter results are expected to be mixed due to softer demand. Brian Vaccaro added that attention is shifting to early-2026 trends and guidance, with potential support from higher tax refunds and stable employment, offset by uncertainties including GLP-1 usage, weather, and broader macro volatility.

Black Rock Coffee Bar, Inc. (NASDAQ:BRCB) owns and operates drive-thru coffee bars in the United States, offering roasted coffees, teas, smoothies, and energy drinks.

5. Netskope, Inc. (NASDAQ:NTSK)

On February 17, 2026, Mizuho lowered its price target on Netskope, Inc. (NASDAQ:NTSK) to $20 from $26 and maintained an Outperform rating. Mizuho reduced targets across the enterprise software group due to recent multiple compressions, though Mizuho said it sees “uncommonly attractive investments in software for those investors who can afford to be somewhat patient.” Mizuho added, “Due to AI disruption fears, sentiment across software is nothing short of horrible at the moment,” while noting that quarterly software checks were solid overall.

Also on February 17, 2026, KeyBanc lowered its price target on Netskope to $17 from $24 and kept an Overweight rating, citing lower peer valuation multiples and steady quarter-over-quarter feedback and results from partners. On February 11, 2026, RBC Capital analyst Matthew Hedberg lowered the price target to $19 from $23 and maintained an Outperform rating as part of a broader Q4 software preview. Matthew Hedberg said negative investor sentiment persists across software and that RBC Capital prefers names with clearer paths to AI monetization and consolidation opportunities in cyber, data, infrastructure, and vertical SaaS. RBC Capital also updated models to reflect significant year-to-date multiple compression.

On February 3, 2026, Netskope announced Netskope One Data Lineage, a solution designed to provide visibility and analytics to track data provenance across environments. The feature, now in preview, is intended to support AI initiatives and compliance requirements, with general availability expected in the first half of 2026.

Netskope, Inc. (NASDAQ:NTSK) provides cloud-native cybersecurity, networking, and analytics solutions through its Netskope One platform to enterprises and mid-sized companies worldwide.

4. eToro Group Ltd. (NASDAQ:ETOR)

On February 18, 2026, BofA raised its price target on eToro Group Ltd. (NASDAQ:ETOR) to $44 from $40 and maintained a Neutral rating. BofA said the company delivered a Q4 adjusted earnings beat driven by stronger net trading contribution from equities, currencies, and commodities, along with lower taxes and a reduced share count. BofA also noted that ECC contribution per trade improved quarter over quarter, supported by elevated commodities trading.

Also on February 18, 2026, Canaccord lowered its price target on eToro Group Ltd. to $65 from $78 and kept a Buy rating. Canaccord said that while crypto markets were weak in Q4, strength in other asset classes and growth in funded accounts led to an approximately 6% sequential increase in net contribution, adding that the Q4 macro backdrop was tougher despite solid execution since going public.

On February 17, 2026, eToro reported Q4 adjusted EPS of 71c, above the 60c consensus estimate, and revenue of $3.87B compared to $5.85B last year. CEO Yoni Assia said, “This was a milestone year for eToro,” highlighting the company’s transition to a publicly traded company and continued build-out of its global financial platform, including product innovation, AI adoption, expanded market access, and geographic growth.

eToro Group Ltd. (NASDAQ:ETOR) operates a multi-asset trading platform supporting equities, crypto assets, commodities, currencies, and options, which can be traded as assets or derivatives.

3. Fermi Inc. (NASDAQ:FRMI)

On February 11, 2026, Fermi Inc. (NASDAQ:FRMI), operating as Fermi America, highlighted progress in its strategic partnership with Hyundai Engineering & Construction Co., Ltd. to advance large-scale nuclear construction in the United States. The companies are continuing Front-End Engineering Design work for four AP1000 units planned for Project Matador, an 11-gigawatt private energy campus outside Amarillo, Texas. Fermi America also participated in Hyundai E&C’s Large-Scale Nuclear Technology Seminar on February 10 in Dallas, which brought together U.S. construction and nuclear industry leaders to discuss execution requirements for large-scale nuclear projects and align contractors and supply chain partners.

On February 9, 2026, Citizens initiated coverage of Fermi with an Outperform rating and a $30 price target. Citizens described Fermi as a “differentiated” digital infrastructure REIT developing a campus near Amarillo that combines high-performance compute data center infrastructure with behind-the-meter power. Citizens said persistent U.S. data center capacity constraints make leasing highly probable in the coming months despite near-term volatility. On January 20, 2026, Texas Capital initiated coverage with a Buy rating and a $23 price target, noting the company is developing what it describes as the world’s largest hybrid energy and data center campus. Texas Capital said Fermi is “uniquely positioned to capitalize” on hyperscalers’ need to bypass long interconnection queues and secure reliable power, adding that the stock reflects only about 10% of projected power capacity at current valuation.

Fermi Inc. (NASDAQ:FRMI) develops electric grids designed to deliver highly redundant, gigawatt-scale power to support artificial intelligence infrastructure.

2. Caris Life Sciences, Inc. (NASDAQ:CAI)

On February 17, 2026, Baird initiated coverage of Caris Life Sciences, Inc. (NASDAQ:CAI) with an Outperform rating and a $26 price target. Baird described Caris Life Sciences, Inc. (NASDAQ:CAI) as a commercial-stage precision oncology company focused on comprehensive molecular information and machine learning algorithms. While Baird sees some uncertainty around pipeline offerings and 2026 consensus estimates, Baird believes the recent stock selloff has created an attractive entry point.

In January, Caris Life Sciences, Inc. (NASDAQ:CAI) reported fourth-quarter revenue of $281M, compared with the $204.31M consensus estimate. The company completed approximately 52,700 clinical therapy selection cases, up about 20%, including roughly 44,150 MI Profile cases and approximately 8,550 Caris Assure cases.

For FY25, Caris Life Sciences, Inc. (NASDAQ:CAI) sees revenue of $800M versus the $723.42M consensus estimate and completed approximately 199,300 clinical therapy selection cases, an increase of 22%, consisting of about 170,300 MI Profile cases and approximately 29,000 Caris Assure cases.

Caris Life Sciences, Inc. (NASDAQ:CAI) is an artificial intelligence TechBio company that provides molecular profiling services and develops solutions using molecular information and machine learning algorithms in the United States and internationally.

1. Solstice Advanced Materials, Inc. (NASDAQ:SOLS)

On February 13, 2026, Mizuho analyst John Roberts raised the price target on Solstice Advanced Materials, Inc. (NASDAQ:SOLS) to $80 from $65 and maintained a Neutral rating, updating estimates following the earnings report.

On February 12, 2026, UBS analyst Joshua Spector increased the price target to $87 from $75 and kept a Buy rating, saying the Q4 beat suggests conservatism in the company’s in-line guidance and that a faster nuclear capacity ramp supports potential earnings revisions. The same day, BMO Capital raised its price target to $90 from $72 and maintained an Outperform rating after Q4 results. BMO Capital noted that amid increased nuclear demand and outlook, Solstice announced a 20% expansion of its UF6 capacity to over 10Kt in 2026.

On February 11, 2026, Solstice reported Q4 revenue of $987M compared with $913M last year. CEO David Sewell said, “I’m pleased to report Solstice’s strong fourth quarter results,” citing momentum tied to data centers, A.I., and nuclear energy. Management highlighted plans to expand nuclear conversion capacity and announced the initiation of a quarterly dividend as part of a disciplined capital allocation approach.

Solstice Advanced Materials, Inc. (NASDAQ:SOLS) is a specialty chemicals and advanced materials company operating through its Refrigerants & Applied Solutions and Electronic & Specialty Materials segments in the United States and internationally.

While we acknowledge the potential of SOLS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SOLS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 10 Most Profitable Undervalued Stocks to Buy 

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.